Condition

Age Related Macular Degeneration (9)

AMD (2)

CNV (1)

Geographic Atrophy (1)

Low Vision (1)

Macular Degeneration (1)

Overall Status

Completed (3)

Recruiting (2)

Withdrawn (2)

Not yet recruiting (1)

Unknown status (1)

Phase

phase 1/phase 2 (2)

phase 1 (1)

phase 2 (1)

phase 3 (1)

Sponsor

The New York Eye & Ear Infirmary (2)

Vitreous -Retina- Macula Consultants of New York (2)

Icahn School of Medicine at Mount Sinai (1)

Ionis Pharmaceuticals, Inc. (1)

Northeastern University (1)

StemCells, Inc. (1)

Weill Medical College of Cornell University (1)

Collaborator

Genentech, Inc. (3)

National Eye Institute (NEI) (2)

Lighthouse Guild (1)

New England College of Optometry (1)

University of California, Los Angeles (1)

iHealthScreen Inc (1)

Intervention

ranibizumab (2)

adaptive optics ao-oct/af instrument (1)

efalizumab, ranibizumab (1)

hucns-sc cells (1)

ionis-fb-lrx (1)

placebo (sterline saline 0.9%) (1)

referrable versus non referral amd diagnostic test (1)

ultrasound examination (1)

visual feedback (1)

Study Documents

Intervention Type

drug (5)

diagnostic test (2)

behavioral (1)

procedure (1)

Funder Type

Other (7)

Industry (2)

Study Type

Interventional (5)

Observational (4)

Age Related Macular Degeneration

Showing NaN - NaN of 9

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED